Enovix Target of Unusually High Options Trading (NASDAQ:ENVX)

Enovix Corporation (NASDAQ:ENVX) was the recipient of some unusual options trading activity on Friday. Investors acquired 29,720 call options on the company. This is an increase of approximately 92% compared to the typical daily volume of 15,487 call options.

Enovix Stock Down 9.0%

Shares of ENVX stock opened at $3.95 on Friday. Enovix has a 52-week low of $3.90 and a 52-week high of $15.40. The stock has a market cap of $861.69 million, a price-to-earnings ratio of -4.76 and a beta of 2.26. The firm’s 50-day moving average is $6.21 and its 200-day moving average is $6.25. The company has a debt-to-equity ratio of 2.14, a quick ratio of 10.65 and a current ratio of 10.97.

Enovix (NASDAQ:ENVX) last announced its quarterly earnings results on Wednesday, May 13th. The company reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.01. The firm had revenue of $7.60 million for the quarter, compared to the consensus estimate of $6.95 million. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.The business’s revenue was up 49.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.15) earnings per share. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. Sell-side analysts predict that Enovix will post -0.79 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Benchmark lowered their price objective on shares of Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a research report on Thursday, May 14th. TD Cowen lowered their target price on Enovix from $7.00 to $5.50 and set a “hold” rating for the company in a report on Friday. Wall Street Zen raised Enovix from a “strong sell” rating to a “sell” rating in a research note on Saturday, May 16th. Oppenheimer cut their price target on Enovix from $24.00 to $21.00 and set an “outperform” rating on the stock in a report on Thursday, May 14th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Enovix in a research report on Wednesday, July 8th. Six research analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $12.50.

Hedge Funds Weigh In On Enovix

Several institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in Enovix by 10.9% during the 4th quarter. Vanguard Group Inc. now owns 17,760,708 shares of the company’s stock worth $129,831,000 after purchasing an additional 1,747,145 shares during the last quarter. Millennium Management LLC grew its holdings in shares of Enovix by 1,038.9% during the 3rd quarter. Millennium Management LLC now owns 1,476,879 shares of the company’s stock worth $14,724,000 after purchasing an additional 1,347,200 shares in the last quarter. Two Sigma Investments LP raised its stake in Enovix by 9,197.1% in the third quarter. Two Sigma Investments LP now owns 1,200,997 shares of the company’s stock valued at $11,974,000 after purchasing an additional 1,188,079 shares in the last quarter. Barclays PLC grew its stake in Enovix by 263.1% during the fourth quarter. Barclays PLC now owns 1,551,941 shares of the company’s stock worth $11,345,000 after buying an additional 1,124,480 shares in the last quarter. Finally, Electron Capital Partners LLC grew its stake in Enovix by 13.8% during the third quarter. Electron Capital Partners LLC now owns 8,038,396 shares of the company’s stock worth $80,143,000 after buying an additional 972,103 shares in the last quarter. 50.92% of the stock is currently owned by institutional investors and hedge funds.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.